Long-term treatment of chronic obstructive lung disease by Nifedipine: an 18-month haemodynamic study. 1988

A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
Department of Cardiology, Centre Hospitalo-Universitaire Nord, Marseille, France.

This long-term controlled study was undertaken to assess the haemodynamic effects of chronic administration of Nifedipine (N). Twenty patients suffering from pulmonary hypertension secondary to chronic obstructive lung disease were divided into two groups. One group (treatment group) was instructed to take 30 mg of N daily and the other (control group) did not take N. Haemodynamic measurements were recorded before and after an 18-month observation period. For patients in the treatment group, Nifedipine was stopped 24 h prior to the second investigation. Acute response to a single dose of Nifedipine (10 mg sublingually) was also evaluated in all patients during the first and second investigations in order to estimate a possible tachyphylaxis. No significant modification in heart rate, mean pulmonary pressure, mean arterial pressure or blood gases was observed. Conversely, a 10% decrease in cardiac output (p less than 0.05) occurred in the control group. Pulmonary vascular response to acute administration of Nifedipine was the same in both groups before and after the observation period. These results suggest that while long-term administration of Nifedipine to patients with chronic obstructive lung disease does not improve pulmonary pressure, it may prevent a decrease in cardiac output. No tachyphylaxis was noted.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
February 1974, Vnitrni lekarstvi,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
September 1987, Ugeskrift for laeger,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
January 1986, Respiration; international review of thoracic diseases,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
August 2006, MMW Fortschritte der Medizin,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
January 1978, Respiration; international review of thoracic diseases,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
January 1989, Plucne bolesti : casopis Udruzenja pneumoftiziologa Jugoslavije = the journal of Yugoslav Association of Phthisiology and Pneumology,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
May 1986, European journal of respiratory diseases,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
May 1978, Praxis und Klinik der Pneumologie,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
May 2001, Ugeskrift for laeger,
A Y Saadjian, and F F Philip-Joet, and R Vestri, and A G Arnaud
January 1985, Arzneimittel-Forschung,
Copied contents to your clipboard!